The Food and Drug Administration today released for comment draft guidance clarifying what types of clinical and patient decision support software would no longer be regulated by the agency as a medical device under the 21st Century Cures Act. FDA Commissioner Scott Gottlieb, M.D., said the guidance generally excludes from regulation software that allows a health care provider or patient to independently review the basis for its treatment recommendations. In addition, FDA released draft guidance clarifying that certain digital health technologies, such as mobile apps intended solely to maintain or encourage a healthy lifestyle, generally fall outside the scope of FDA regulation under the Act, and final guidance adopting international principles for harmonizing the regulation of software with a medical purpose.

Related News Articles

Headline
The Food and Drug Administration yesterday released a safety notice announcing a software patch is available to address cybersecurity vulnerabilities in…
Headline
The Cybersecurity and Infrastructure Security Agency, FBI, Department of Defense Cyber Crime Center and the National Security Agency June 30 released a fact…
Headline
The Centers for Medicare & Medicaid Services June 27 announced the rollout of a 6-year technology-enabled prior authorization program pilot. Through…
Headline
The Centers for Medicare & Medicaid Services today announced it has identified a fraud scheme targeting Medicare providers and suppliers. CMS said scammers…
Headline
The Joint Commission June 11 announced a new partnership with the Coalition for Health AI to help accelerate the development and adoption of best practices and…
Headline
The FBI, Cybersecurity and Infrastructure Security Agency and Australian Cyber Security Centre June 4 released an advisory on updated actions and tactics used…